ZhengR, ZhangS, ZengH, et al.Cancer incidence and mortality in China, 2016. JNCC, 2022; 2(1):1–9; doi: 10.1016/j.jncc.2022.02.002
2.
LiM, ZhengR, LuiginoD, et al.Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes Endocrinol, 2021; 9(6):330–332; doi: 10.1016/S2213-8587(21)00083-8
3.
SugitaniI, ItoY, TakeuchiD, et al.Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: Consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma. Thyroid, 2021; 31(2):183–192; doi: 10.1089/thy.2020.0330
4.
ChouR, DanaT, HaymartM, et al.Active Surveillance versus thyroid surgery for differentiated thyroid cancer: A systematic review. Thyroid, 2022; 32(4):351–367; doi: 10.1089/thy.2021.0539
5.
SasakiT, MiyauchiA, FujishimaM, et al.Comparison of postoperative unfavorable events in patients with low-risk papillary thyroid carcinoma: Immediate surgery versus conversion surgery following active surveillance. Thyroid, 2023; 33(2):186–191; doi: 10.1089/thy.2022.0444
6.
GaoM, GeM, JiQ, et al.2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med, 2017; 14(3):203–211; doi: 10.20892/j.issn.2095-3941.2017.0051
7.
HuY, CaoX, ZhouY, et al.Management of sonographically suspicious thyroid nodules 1 cm or smaller and candidacy for active surveillance: Experience of a tertiary center in China. Endocr Pract, 2021; 27(9):903–911; doi: 10.1016/j.eprac.2021.02.006
8.
LiuW, CaoW, DongZ, et al.Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population. Endocr Pract, 2022; 28(4):391–397; doi: 10.1016/j.eprac.2022.01.013
9.
ZhuP, ZhangQ, WuQ, et al.Barriers and facilitators to the choice of active surveillance for low-risk papillary thyroid cancer in China: A qualitative study examining patient perspectives. Thyroid, 2023; 33(7):826–834; doi: 10.1089/thy.2022.0347
10.
NickelB, BritoJP, MoynihanR, et al.Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: A qualitative study. BMC Cancer, 2018; 18(1):242; doi: 10.1186/s12885-018-4152-9
11.
PittSC, SauckeMC, RomanBR, et al.The influence of emotions on treatment decisions about low-risk thyroid cancer: A qualitative study. Thyroid, 2021; 31(12):1800–1807; doi: 10.1089/thy.2021.0323
12.
SawkaAM, GhaiS, RotsteinL, et al.A quantitative analysis examining patients' choice of active surveillance or surgery for managing low-risk papillary thyroid cancer. Thyroid, 2022; 32(3):255–262; doi: 10.1089/thy.2021.0485
13.
KarciogluAS, DhillonVK, DaviesL, et al.Analysis of unmet information needs among patients with thyroid cancer. JAMA Otolaryngol Head Neck Surg, 2023; 149(2):110–119; doi: 10.1001/jamaoto.2022.4108
14.
LeeEK, MoonJH, HwangboY, et al.Progression of low-risk papillary thyroid microcarcinoma during active surveillance: Interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro) in Korea. Thyroid, 2022; 32(11):1328–1336; doi: 10.1089/thy.2021.0614
15.
DaviesL. How will we know when the “Right” number of people choose active surveillance?. Thyroid, 2022; 32(7):750–751; doi: 10.1089/thy.2022.0262
